- Erratum
- Open access
- Published:
Erratum to: Patient costs of breast cancer endocrine therapy agents under Medicare Part D vs with generic formulations
SpringerPlus volume 4, Article number: 531 (2015)
Erratum to: SpringerPlus (2015) 4:54 DOI 10.1186/s40064-015-0827-8
Author information
Authors and Affiliations
Corresponding author
Additional information
The online version of the original article can be found under doi:10.1186/s40064-015-0827-8.
Rights and permissions
Open access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
About this article
Cite this article
Nattinger, A.B., Pezzin, L.E., McGinley, E.L. et al. Erratum to: Patient costs of breast cancer endocrine therapy agents under Medicare Part D vs with generic formulations. SpringerPlus 4, 531 (2015). https://doi.org/10.1186/s40064-015-1233-y
Published:
DOI: https://doi.org/10.1186/s40064-015-1233-y